MSCs and MSC-Exos in pediatric ARDS treatment: translational research and the reshaping of nursing roles

Area of Science:

• Regenerative Medicine
• Pediatric Pulmonology
• Cell-based Therapies

Background:

• Pediatric Acute Respiratory Distress Syndrome (ARDS) presents a significant clinical challenge with high mortality rates.
• Current treatments for pediatric ARDS are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the current state of knowledge regarding Mesenchymal Stem Cells (MSCs) and Mesenchymal Stem Cell-derived Exosomes (MSC-Exos) for pediatric ARDS.
• To examine the progress of MSC and MSC-Exo research from preclinical studies to human trials.
• To identify challenges and evolving nursing roles in implementing these advanced cell therapies.

Main Methods:

• Literature review of preclinical and clinical studies on MSCs and MSC-Exos in pediatric ARDS.
• Analysis of the therapeutic mechanisms, including anti-inflammatory, immunomodulatory, and tissue-repair functions.
• Exploration of clinical trial data and nursing implications.

Main Results:

• MSCs and MSC-Exos demonstrate significant therapeutic potential for pediatric ARDS due to their regenerative properties.
• Evidence from early-stage and ongoing human trials supports the efficacy and safety of these cell-based therapies.
• The review highlights the need for specialized nursing competencies to manage patients receiving advanced cell therapies.

Conclusions:

• MSCs and MSC-Exos represent a promising frontier in treating pediatric ARDS, offering hope for improved patient outcomes.
• The integration of these novel therapies requires a proactive evolution of nursing practice and education.
• Developing a robust nursing framework is crucial for the successful implementation and patient care in advanced cell therapy settings.